Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects

Dihydroartemisinin-piperaquine is an artemisinin-based combination treatment (ACT) recommended by the WHO for uncomplicated Plasmodium falciparum malaria, and it is being used increasingly for resistant vivax malaria where combination with primaquine is required for radical cure. The WHO recently re...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Hanboonkunupakarn, Borimas, Ashley, Elizabeth A., Jittamala, Podjanee, Tarning, Joel, Pukrittayakamee, Sasithon, Hanpithakpong, Warunee, Chotsiri, Palang, Wattanakul, Thanaporn, Panapipat, Salwaluk, Lee, Sue J., Day, Nicholas P. J., White, Nicholas J.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Clinical Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249579/
https://ncbi.nlm.nih.gov/pubmed/25267661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03704-14
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items